Archiv der Pharmazie

Article	Citations
Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors	184
1,2,3‐Triazole hybrids as anticancer agents: A review	150
Novel benzoic acid derivatives: Synthesis and biological evaluation as multitarget acetylcholinesterase and carbonic anhydrase inhibitors	70
Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds	69
1,3,5‐Triazine: A versatile pharmacophore with diverse biological activities	62
Design, synthesis, and biological activity of novel dithiocarbamate‐methylsulfonyl hybrids as carbonic anhydrase inhibitors	56
Recent update on antibacterial and antifungal activity of quinoline scaffolds	52
Design and discovery of new 1,2,4‐triazolo[4,3‐c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors	50
Pharmacophore‐linked pyrazolo[3,4‐d]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies	49
Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone‐based benzenesulfonamides	45
Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms	43
Phthalazine‐based VEGFR‐2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations	39
Synthesis of N‐alkylated pyrazolo[3,4‐d]pyrimidine analogs and evaluation of acetylcholinesterase and carbonic anhydrase inhibition properties	36
Design, synthesis, molecular modeling, and antimicrobial potential of novel 3‐[(1H‐pyrazol‐3‐yl)imino]indolin‐2‐one derivatives as DNA gyrase inhibitors	35
Discovery of novel pyrazole and pyrazolo[1,5‐a]pyrimidine derivatives as cyclooxygenase inhibitors (COX‐1 and COX‐2) using molecular modeling simulation	34
In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors	33
Anticancer activity of novel 3‐(furan‐2‐yl)pyrazolyl and 3‐(thiophen‐2‐yl)pyrazolyl hybrid chalcones: Synthesis and in vitro studies	33
Synthesis and biological evaluation of some 1‐naphthol derivatives as antioxidants, acetylcholinesterase, and carbonic anhydrase inhibitors	32
Pyridine‐derived VEGFR‐2 inhibitors: Rational design, synthesis, anticancer evaluations, in silico ADMET profile, and molecular docking	31
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase	31
Oxadiazole: A highly versatile scaffold in drug discovery	31
Cinnamic acid hybrids as anticancer agents: A mini‐review	30
Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors	30
Azetidines of pharmacological interest	28
Design, synthesis, molecular docking, and some metabolic enzyme inhibition properties of novel quinazolinone derivatives	27

N‐Substituted‐4‐phenylphthalazin‐1‐amine‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluation studies	27
Synthesis, characterization, and biological evaluation of some novel Schiff bases as potential metabolic enzyme inhibitors	26
Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development	25
In vitro and in silico studies of fluorinated 2,3‐disubstituted thiazolidinone‐pyrazoles as potential α‐amylase inhibitors and antioxidant agents	24
Synthesis of novel sulfonamides with anti‐Alzheimer and antioxidant capacities	24
Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure–activity relationship, and mechanisms of action (2019–2021)	24
Cytotoxic and antimicrobial potential of benzimidazole derivatives	23
Synthesis, molecular docking, and biological activities of new cyanopyridine derivatives containing phenylurea	23
Design, synthesis, and biological evaluation of novel morpholinated isatin–quinoline hybrids as potent anti‐breast cancer agents	23
Synthesis and in vitro study of antiproliferative benzyloxy dihydropyrimidinones	23
Ginkgo biloba in the management of the COVID‐19 severity	23
(+)‐Camphor and (−)‐borneol derivatives as potential anti‐orthopoxvirus agents	23
Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4‐hydroxy‐3,5‐dimethoxy benzaldehyde motif	22
Design, synthesis, and biological evaluation of isatin‐indole‐3‐carboxaldehyde hybrids as a new class of xanthine oxidase inhibitors	21
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors	21
Advances in 2‐substituted benzothiazole scaffold‐based chemotherapeutic agents	21
The anticancer activity of carbazole alkaloids	20
Synthesis and anticancer properties of novel hydrazone derivatives incorporating pyridine and isatin moieties	20
Biological functions of kojic acid and its derivatives in medicine, cosmetics, and food industry: Insights into health aspects	19
Discovery of novel furo[2,3‐d]pyrimidin‐2‐one–1,3,4‐oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis	19
A comprehensive review of recent advances in the biological activities of 1,2,4‐oxadiazoles	19
In silico molecular docking studies of oxadiazole and pyrimidine bearing heterocyclic compounds as potential antimicrobial agents	18
Potential antibacterial and antifungal activities of novel sulfamidophosphonate derivatives bearing the quinoline or quinolone moiety	18
Phyllobilins as a challenging diverse natural product class: Exploration of pharmacological activities	18
Design, synthesis, and molecular docking studies of thiazolidinediones as PPAR‐γ agonists and thymidylate synthase inhibitors	18
Synthesis, characterization, crystal structure, α‐glycosidase, and acetylcholinesterase inhibitory properties of 1,3‐disubstituted benzimidazolium salts	17
Thiophene‐containing compounds with antimicrobial activity	17
Isatin thiazoles as antidiabetic: Synthesis, in vitro enzyme inhibitory activities, kinetics, and in silico studies	17
Exploration of thiazolidine‐2,4‐diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations	16
Novel N‐benzylpiperidine derivatives of 5‐arylisoxazole‐3‐carboxamides as anti‐Alzheimer's agents	16
Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase‐B inhibitors	16
Design, synthesis, and characterization of PROTACs targeting the androgen receptor in prostate and lung cancer models	16
Novel benzenesulfonamide‐bearing pyrazoles and 1,2,4‐thiadiazoles as selective carbonic anhydrase inhibitors	16
Novel 2‐substituted thioquinazoline‐benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity	16
Novel promising benzoxazole/benzothiazole‐derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis	15
Silver–N‐heterocyclic carbene complexes‐catalyzed multicomponent reactions: Synthesis, spectroscopic characterization, density functional theory calculations, and antibacterial study	15
Pharmacological report of recently designed multifunctional coumarin and coumarin–heterocycle derivatives	14
Discovery of oxindole‐based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation	14
New quinoxalin‐1,3,4‐oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies	14
Synthesis and anticancer activity of ethyl 5‐amino‐1‐N‐substituted‐imidazole‐4‐carboxylate building blocks	14
Synthesis and docking calculations of tetrafluoronaphthalene derivatives and their inhibition profiles against some metabolic enzymes	14
New indomethacin analogs as selective COX‐2 inhibitors: Synthesis, COX‐1/2 inhibitory activity, anti‐inflammatory, ulcerogenicity, histopathological, and docking studies	14
Synthesis of new 7‐amino‐3,4‐dihydroquinolin‐2(1H)‐one‐peptide derivatives and their carbonic anhydrase enzyme inhibition, antioxidant, and cytotoxic activities	14
1,2,4‐Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities	14
Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine‐1,1‐dioxide derivatives	14
Bioevaluation of synthetic pyridones as dual inhibitors of α‐amylase and α‐glucosidase enzymes and potential antioxidants	13
Targeting VEGFR‐2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies	13
Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives	13
The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers	13
New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes	13

Novel isoxazoline‐linked 1,3,4‐thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation	13
Investigation of the carbonic anhydrase inhibitory activity of benzenesulfonamides incorporating substituted fused‐pyrimidine tails	12
Upregulation of BAX and caspase‐3, as well as downregulation of Bcl‐2 during treatment with indeno[1,2‐b]quinoxalin derivatives, mediated apoptosis in human cancer cells	12
Some phenolic natural compounds as carbonic anhydrase inhibitors: An in vitro and in silico study	12
Synthesis and antimalarial and anticancer evaluation of 7‐chlorquinoline‐4‐thiazoleacetic derivatives containing aryl hydrazide moieties	12
Potential targeting of Hep3B liver cancer cells by lupeol isolated from Avicennia marina	12
Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment	12
Design, synthesis, and α‐glucosidase‐inhibitory activity of phenoxy‐biscoumarin–N‐phenylacetamide hybrids	12
Synthesis and evaluation of novel xanthene‐based thiazoles as potential antidiabetic agents	12
Influence of the pKa value on the antioxidant activity of licorice flavonoids under solvent‐mediated effects	12
Green synthesis of pregabalin‐stabilized gold nanoclusters and their applications in sensing and drug release	12
Synthesis and biological evaluation of new coumarin derivatives as cytotoxic agents	12
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers	12
Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19	11
Synthesis and evaluation of multitarget new 2‐aminothiazole derivatives as potential anti‐Alzheimer's agents	11
Facile synthesis of C6‐substituted benz[4,5]imidazo[1,2‐a]quinoxaline derivatives and their anticancer evaluation	11
Antitumor and multikinase inhibition activities of some synthesized coumarin and benzofuran derivatives	11
Piperazine and piperidine‐substituted 7‐hydroxy coumarins for the development of anti‐inflammatory agents	11
Synthesis of vanillin derivatives with 1,2,3‐triazole fragments and evaluation of their fungicide and fungistatic activities	10
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands	10
Molecular hydrogen (H2) as a potential treatment for acute and chronic fatigue	10
Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3‐c]quinazolines as classical DNA intercalators	10
Novel hydrazone‐isatin derivatives as potential EGFR inhibitors: Synthesis and in vitro pharmacological profiling	10
Development of methylated cobalt–alkyne complexes with selective cytotoxicity against COX‐positive cancer cell lines	10
Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX‐2 inhibitors	10
Current perspectives on naturally occurring saponins as anticancer agents	10
The antimalarial activity of 1,2,4‐trioxolane/trioxane hybrids and dimers: A review	10
Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies	10
Drug re‐engineering and repurposing: A significant and rapid approach to tuberculosis drug discovery	10
Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR‐2 inhibitors	10
Zinc(II) complexation strategy for ultra‐sensitive fluorimetric estimation of molnupiravir: Applications and greenness evaluation	10
3D‐QSAR and scaffold hopping based designing of benzo[d]ox‐azol‐2(3H)‐one and 2‐oxazolo[4,5‐b]pyridin‐2(3H)‐one derivatives as selective aldehyde dehydrogenase 1A1 inhibito	10
Simultaneous analysis of oxytetracycline hydrochloride, lidocaine, and bromhexine hydrochloride in the presence of many interfering excipients	10
Antiprotozoal agents: How have they changed over a decade?	10
Insights into the chemistry and therapeutic potential of acrylonitrile derivatives	10
Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin–1,2,4‐triazole scaffolds	10
Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease	10
Phthalimide‐tethered imidazolium salts: Synthesis, characterization, enzyme inhibitory properties, and in silico studies	9
Triazoloquinazoline derived classical DNA intercalators: Design, synthesis, in silico ADME profile, docking, and antiproliferative evaluations	9
Novel quinazoline–chromene hybrids as anticancer agents: Synthesis, biological activity, molecular docking, dynamics and ADME studies	9
Design, synthesis, biological evaluation, and in silico studies of 2‐aminobenzothiazole derivatives as potent PI3Kα inhibitors	9
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties	9
Cyanopropyl functionalized benzimidazolium salts and their silver N‐heterocyclic carbene complexes: Synthesis, antimicrobial activity, and theoretical analysis	9
Pyrazole/pyrazoline as an excellent pharmacophore in the design of carbonic anhydrase inhibitors (2018–2022)	9
Design and synthesis of benzenesulfonamide‐linked imidazo[2,1‐b][1,3,4]thiadiazole derivatives as carbonic anhydrase I and II inhibitors	9
Binding of boswellic acids to functional proteins of the SARS‐CoV‐2 virus: Bioinformatic studies	9
Synthesis and biological evaluation of novel isoxazole derivatives from acridone	9
Mechanistic study of the antibacterial potential of the prenylated flavonoid auriculasin against Escherichia coli	9
Design, synthesis, and molecular docking study of novel quinoline‐based bis‐chalcones as potential antitumor agents	9
Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action	9
Discovery of novel triazolophthalazine derivatives as DNA intercalators and topoisomerase II inhibitors	9
New pyrimidine/thiazole hybrids endowed with analgesic, anti‐inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX‐2/sEH dual inhibition	9
New 1,3,4‐oxadiazole‐chalcone/benzimidazole hybrids as potent antiproliferative agents	9
Synthesis and antitumor potential of new arylidene ursolic acid derivatives via caspase‐8 activation	9
Design, synthesis, and in silico studies of tetrahydropyrimidine analogs as urease enzyme inhibitors	9
Synthesis, docking studies, and pharmacological evaluation of 2‐hydroxypropyl‐4‐arylpiperazine derivatives as serotoninergic ligands	9
A new series of hydrazones as small‐molecule aldose reductase inhibitors	9
Anti‐inflammatory activity of pyridazinones: A review	9
Synthesis of new 1,2,4‐triazole–(thio)semicarbazide hybrid molecules: Their tyrosinase inhibitor activities and molecular docking analysis	9
Bioevaluation of quinoline‐4‐carbonyl derivatives of piperazinyl‐benzothiazinones as promising antimycobacterial agents	9
Comparative analysis of apocarotenoids and phenolic constituents of Crocus sativus stigmas from 11 countries: Ecological impact	9
Synthesis, structural characterization, and biological studies of ATBS–M complexes (M(II) = Cu, Co, Ni, and Mn): Access for promising antibiotics and anticancer agents	8
Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor	8
Investigation of tyrosinase enzyme (from mushroom) inhibitory activities and antioxidant properties of new fluorine‐containing phthalocyanines	8
The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review	8
New 3‐(1H‐benzo[d]imidazol‐2‐yl)quinolin‐2(1H)‐one‐based triazole derivatives: Design, synthesis, and biological evaluation as antiproliferative and apoptosis‐inducing agents	8
New [1,2,4]triazolo[4,3‐c]quinazoline derivatives as vascular endothelial growth factor receptor‐2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluatio	8
Synthesis and SARs study of novel spiro‐oxindoles as potent antiproliferative agents with CDK‐2 inhibitory activities	8
Review of β‐carboline and its derivatives as selective MAO‐A inhibitors	8
Eugenol carbonate activity against Plasmodium falciparum, Leishmania braziliensis, and Trypanosoma cruzi	8
Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5‐nitrothiophene derivatives for anticancer activity	8
Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis	8
Dihydropyrimidinones as potent anticancer agents: Insight into the structure–activity relationship	8
Potential of triazines in Alzheimer's disease: A versatile privileged scaffold	8
Design, synthesis, molecular docking, and biological evaluation of coumarin‐thymidine analogs as potent anti‐TB agents	8
Hybridization‐based design of novel anticholinesterase indanone–carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies	8
Indole clubbed 2,4‐thiazolidinedione linked 1,2,3‐triazole as a potent antimalarial and antibacterial agent against drug‐resistant strain and molecular modeling studies	8
Synthesis and biological evaluation of coumarin‐thiazole hybrids as selective carbonic anhydrase IX and XII inhibitors	8
Developing a scaffold for urease inhibition based on benzothiazoles: Synthesis, docking analysis, and therapeutic potential	7
Recent advances in the development of celecoxib analogs as anticancer agents: A review	7

Design and synthesis of novel quinazolinone‐based fibrates as PPARα agonists with antihyperlipidemic activity	7
Exploring ibuprofen derivatives as α‐glucosidase and lipoxygenase inhibitors: Cytotoxicity and in silico studies	7
Novel substituted 5‐methyl‐4‐acylaminoisoxazoles as antimitotic agents: Evaluation of selectivity to LNCaP cancer cells	7
Benzenesulfonamides with trisubstituted triazole motif as selective carbonic anhydrase I, II, IV, and IX inhibitors	7
2‐Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors	7
Chrysin: A polyedric flavone as a tool to explore new phytotherapeutic applications and drug design	7
New PEPPSI‐Pd‐NHC complexes bearing 4‐hydroxyphenylethyl group: Synthesis, characterization, molecular docking, and bioactivity properties	7
Design, synthesis, and biological evaluation of 1,2,4‐oxadiazole‐containing pyrazolo[3,4‐b]pyridinones as a new series of AMPKɑ1β1γ1 activators	7
Therapeutic potential of 1,2,3‐triazole hybrids for leukemia treatment	7
3‐Aryl‐substituted imidazo[1,2‐a]pyridines as antituberculosis agents	7
Quinoxaline‐based efflux pump inhibitors restore drug susceptibility in drug‐resistant nontuberculous mycobacteria	7
Quinazoline‐tethered hydrazone: A versatile scaffold toward dual anti‐TB and EGFR inhibition activities in NSCLC	7
Design, synthesis, and antiproliferative effect of 2,9‐bis[4‐(pyridinylalkylaminomethyl)phenyl]‐1,10‐phenanthroline derivatives on human leukemic cells by targeting G‐quadruplex	7
Development of new Alzheimer's disease drug candidates using donepezil as a key model	7
Tandem synthesis, cytotoxicity, and in silico study of new 1,3,4‐oxadiazoles as potential thymidylate synthase inhibitors	7
Design, synthesis, structure elucidation, antimicrobial, molecular docking, and SAR studies of novel urea derivatives bearing tricyclic aromatic hydrocarbon rings	7
Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase	7
New quinazolinone‐based derivatives as DHFR/EGFR‐TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity	7
Design, synthesis, and biological evaluation of new celecoxib analogs as apoptosis inducers and cyclooxygenase‐2 inhibitors	7
Design, synthesis, anticancer, and docking of some S‐ and/or N‐heterocyclic derivatives as VEGFR‐2 inhibitors	7
Unveiling the chemistry of 1,3,4‐oxadiazoles and thiadiazols: A comprehensive review	6
Effective chiral pool synthesis of both enantiomers of the TRPML inhibitor trans‐ML‐SI3	6
Design, synthesis, and molecular docking of novel 3,5‐disubstituted‐1,3,4‐oxadiazole derivatives as iNOS inhibitors	6
Linked biaromatic compounds as cardioprotective agents	6
Flucytosine‐based prodrug activation by cold physical plasma	6
First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights	6
The C‐terminally shortened analogs of a hexapeptide derived from Lingzhi hydrolysate with enhanced tyrosinase‐inhibitory activity	6
Synthesis of new thienylnicotinamidines: Proapoptotic profile and cell cycle arrest of HepG2 cells	6
Pyrazolo[3,4‐d]pyrimidine scaffold: A review on synthetic approaches and EGFR and VEGFR inhibitory activities	6
Potent inhibitors of tumor associated carbonic anhydrases endowed with cathepsin B inhibition	6
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure‐based virtual screening	6
Quantum dots in the biomedical world: A smart advanced nanocarrier for multiple venues application	6
Silver(I) pyridinyl complexes with benzothiazole, thiophene, and furan moieties: DNA/protein‐binding, antibacterial, antioxidant, and anticancer studies	6
Design, synthesis, in silico, and in vitro evaluation of 3‐phenylpyrazole acetamide derivatives as antimycobacterial agents	6
Development, synthesis, and biological evaluation of sulfonyl‐α‐l‐amino acids as potential anti‐Helicobacter pylori and IMPDH inhibitors	6
5‐Arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5H)‐ones with selective inhibitory activity against some leukemia cell lines	6
Anticancer 5‐arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5H)‐ones as tubulin inhibitors	6
Design and development of novel series of indole‐3‐sulfonamide ureido derivatives as selective carbonic anhydrase II inhibitors	6
Fintiamin: A diketopiperazine from the marine sponge‐derived fungus Eurotium sp.	6
Garcinol from Garcinia indica inhibits HIV‐1 reverse transcriptase‐associated ribonuclease H	6
The medicinal panorama of benzimidazoles and their scaffolds as anticancer and antithrombotic agents: A review	6
New functionalized 6‐thienylpyrimidine‐5‐carbonitriles as antiproliferative agents against human breast cancer cells	6
Thienopyrimidine‐based agents bearing diphenylurea: Design, synthesis, and evaluation of antiproliferative and antiangiogenic activity	6
New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents	6
1,5‐Benzoxazepines as a unique and potent scaffold for activity drugs: A review	6
Design, synthesis, antimicrobial activity and molecular docking study of cationic bis‐benzimidazole‐silver(I) complexes	6
Phytochemical characterization and effects on cell proliferation ofPinus nigraArn. bark	6
Synthesis of 2‐(N‐cyclicamino)quinoline combined with methyl (E)‐3‐(2/3/4‐aminophenyl)acrylates as potential antiparasitic agents	6
Curcumin‐based bioactive heterocycles derived via multicomponent reactions	6
Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking	6
A novel class for carbonic anhydrases inhibitors and evaluation of their non‐zinc binding	6
Investigation of selective retinoic acid receptor alpha antagonist ER‐50891 and related analogs for male contraception	6
Anticancer agents incorporating the N‐acylhydrazone scaffold: Progress from 2017 to present	6
Synthesis of novel 2‐acetamide‐5‐phenylthio‐1,3,4‐thiadiazole‐containing phenyl urea derivatives as potential VEGFR‐2 inhibitors	5
Synthesis of novel cyanine dyes as antitumor agents	5
Microwave‐assisted N‐alkylation of amines with alcohols catalyzed by MnCl2: Anticancer, docking, and DFT studies	5
Cytotoxic derivatives of dichloroacetic acid and some metal complexes	5
Nanomolar potency of imidazo[2,1‐b]thiazole analogs as indoleamine 2,3‐dioxygenase inhibitors	5
Multitarget‐directed therapeutics: (Urea/thiourea)2 derivatives of diverse heterocyclic‐Lys conjugates	5
Absolute configuration of cytotoxic anthraquinones from a Brazilian cave soil‐derived fungus, Aspergillus sp. SDC28	5
Repurposing of investigational cancer drugs: Early phase discovery of dengue virus NS2B/NS3 protease inhibitors	5
Thermodynamic characterization of a macrocyclic Zika virus NS2B/NS3 protease inhibitor and its acyclic analogs	5
Unraveling the chemical profile, antioxidant, enzyme inhibitory, cytotoxic potential of different extracts from Astragalus caraganae	5
Azobenzene derivatives with activity against drug‐resistant Candida albicans and Candida auris	5
Imidazopyridine chalcones as potent anticancer agents: Synthesis, single‐crystal X‐ray, docking, DFT and SAR studies	5
A review: Biological activities of novel cyanopyridine derivatives	5
Prevalence of nitrosamine contaminants in drug samples: Has the crisis been overcome?	5
Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4‐b]pyridines with potential p38α MAPK‐inhibitory activity	5
Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2	5
Synthesis of oxazolo‐annulated 3‐benzazepines designed by merging two negative allosteric NMDA receptor modulators	5
Polyhydroxybenzoic acid derivatives as potential new antimalarial agents	5
Synthesis, characterization, biochemical, and molecular modeling studies of carvacrol‐based new thiosemicarbazide and 1,3,4‐thiadiazole derivatives	5
Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation	5
Tail approach synthesis of triazolylthiazolotriazole bearing benzenesulfonamides as carbonic anhydrase inhibitors capable of inducing apoptosis	5
BC‐11 is a covalent TMPRSS2 fragment inhibitor that impedes SARS‐CoV‐2 host cell entry	5
New chimeric HDAC inhibitors for the treatment of colorectal cancer	5
1,2,3‐Triazole‐based esters and carboxylic acids as nonclassical carbonic anhydrase inhibitors capable of cathepsin B inhibition	5
Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds	5
Natural cyclic polypeptides as vital phytochemical constituents from seeds of selected medicinal plants	5
New quinoxalin‐2(1H)‐one‐derived VEGFR‐2 inhibitors: Design, synthesis, in vitro anticancer evaluations, in silico ADMET, and docking studies	5
Synthesis and biological evaluation of 3,5‐diaryl‐pyrazole derivatives as potential antiprostate cancer agents	5
Design, synthesis, α‐glucosidase inhibition, pharmacokinetic, and cytotoxic studies of new indole‐carbohydrazide‐phenoxy‐N‐phenylacetamide derivatives	4
Synthesis of benzylated amine‐substituted xanthone derivatives and their antioxidant and anti‐inflammatory activities	4
Triazolo‐linked benzimidazoles as tubulin polymerization inhibitors and DNA intercalators: Design, synthesis, cytotoxicity, and docking studies	4
Isobavachalcone suppresses the TRIF‐dependent signaling pathway of Toll‐like receptors	4
New 1,2,4‐oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity	4
Replacing the oxidation‐sensitive triaminoaryl chemotype of problematic KV7 channel openers: Exploration of a nicotinamide scaffold	4
Synthesis of cinnamils and quinoxalines and their biological evaluation as anticancer agents	4
Anticancer activities, structure–activity relationship, and mechanism of action of 12‐, 14‐, and 16‐membered macrolactones	4
Indole derivatives targeting colchicine binding site as potential anticancer agents	4
Design, synthesis, and biological evaluation of 5‐aminotetrahydroquinoline‐based LSD1 inhibitors acting on Asp375	4
Fragment‐type 4‐azolylcoumarin derivatives with anticancer properties	4
Benzotriazole scaffold: An overview of antiproliferative potential, mechanisms of action, and structure–activity relationships	4
Synthesis and biological evaluation of sulfonamide‐based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae	4
Selective cytotoxicity of ent‐kaurene diterpenoids isolated from Baccharis lateralis and Baccharis retusa (Asteraceae)	4